Navigation Links
SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device
Date:4/17/2013

JERUSALEM, April 17, 2013 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of technologies that reduces errors and eliminates pain during the administration of prescription medications, announced today that the company intends to hire a Project Manager to oversee and implement a marketing strategy to commercialize its newly acquired painless injection device.

The company's new technology is fully approved by the Federal Drug Administration (FDA), and has demonstrated itself to be safe and effective in actively reducing pain during the administration of blood tests, lanching and injections - a daily reality for many during ongoing medical care.

Both EZJect and Quickool - the newly acquired technologies - received FDA approval for commercialization in 2007.

"To acquire technology that already has FDA approval, is a major step toward full commercialization in the United States," said Akiva Schonfled, Chief Executive Officer of SafeCode Drug Technologies.  "These technologies have applications in hospitals, doctor's offices and clinics, in addition to the at-home, individual care markets. We are confident that with the right project manager in place, we can implement a winning commercialization strategy."

About SafeCode Drug Technologies

SafeCode Drug Technologies is the developer of patent-pending technologies that reduce errors and eliminate pain during the administration of prescription medications. The company's initial technology is voice-activated administration technology that ensures the proper medication is administered to the proper patient. The company's newly acquired EZJect technology eliminates pain during blood tests and injections.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securit
'/>"/>

SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
2. SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
3. SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the Worlds First Voice Recognition Drug Safety Application Prototype
4. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
5. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
6. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
7. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
8. Antibody Technologies and Attrition Rates - An Industry Analysis 2013
9. Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
10. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
11. Multisorb Technologies Non-Toxic StabilOx Oxygen Absorbing Canisters Provide Worry-Free Drug Stability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 /PRNewswire/ ... investigating whether certain officers and directors of ConforMIS, ... of 1934.  ConforMIS is a medical technology company that ... and sell joint replacement implants that are individually sized ... View this press release on the law firm,s ...
(Date:9/1/2015)... -- On August 31, 2015, United States District Judge ... order in the first of the consolidated MDL cases ... devices are defective.[1]  The Court denied ... Christiansen,s claims for defective design, fraudulent misrepresentation and concealment ... claim that the Medical Device Amendment to the Food ...
(Date:9/1/2015)... , Sept. 1, 2015  Amgen (NASDAQ: ... with Novartis in the areas of Alzheimer,s disease ... into Alzheimer,s disease by teaming up with Novartis ... program directed at genetically predisposed individuals at risk ... to focus on the commercialization of its migraine ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9
... Calif., Aug. 3, 2011 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... 2011 were $111.2 million, a 17 percent increase over ... 2010. Results for all periods of fiscal ...
... Calif., Aug. 3, 2011 Onyx Pharmaceuticals, Inc. (NASDAQ: ... second quarter 2011. Onyx reported a non-GAAP net loss of ... quarter 2011 compared to a non-GAAP net income of $2.9 ... in 2010. Non-GAAP net loss excludes, among other items, adjustments ...
Cached Medicine Technology:Thoratec Reports Second Quarter Revenue Increase of 17 Percent 2Thoratec Reports Second Quarter Revenue Increase of 17 Percent 3Thoratec Reports Second Quarter Revenue Increase of 17 Percent 4Thoratec Reports Second Quarter Revenue Increase of 17 Percent 5Thoratec Reports Second Quarter Revenue Increase of 17 Percent 6Thoratec Reports Second Quarter Revenue Increase of 17 Percent 7Thoratec Reports Second Quarter Revenue Increase of 17 Percent 8Thoratec Reports Second Quarter Revenue Increase of 17 Percent 9Thoratec Reports Second Quarter Revenue Increase of 17 Percent 10Thoratec Reports Second Quarter Revenue Increase of 17 Percent 11Thoratec Reports Second Quarter Revenue Increase of 17 Percent 12Thoratec Reports Second Quarter Revenue Increase of 17 Percent 13Thoratec Reports Second Quarter Revenue Increase of 17 Percent 14Thoratec Reports Second Quarter Revenue Increase of 17 Percent 15Thoratec Reports Second Quarter Revenue Increase of 17 Percent 16Thoratec Reports Second Quarter Revenue Increase of 17 Percent 17Thoratec Reports Second Quarter Revenue Increase of 17 Percent 18Thoratec Reports Second Quarter Revenue Increase of 17 Percent 19Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results 10
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Economics, the author explained how many dental practices across the country are switching ... Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora ...
(Date:9/1/2015)... ... , ... According to a study published August 25th in the ... a three year study about weight loss and diabetes were far more likely to ... surgery at the onset of the trial. In fact, the participants in the trial ...
(Date:9/1/2015)... ... ... Celebrity hairstylist and Beauty Gives Back Art Team member Ted Gibson in ... Oct. 1, at the La Valencia Hotel. The presentation, on the eve of Fashion ... professional hair, makeup and nail design. , The evening of beauty and fashion ...
(Date:9/1/2015)... ... 2015 , ... Georgia State University and its partners have ... stemming sexual assaults on their campuses. , The free, evidence-based survey was developed ... researchers and student affairs professionals responding to calls by the Obama Administration to ...
(Date:9/1/2015)... Jose, CA (PRWEB) , ... September 01, 2015 ... ... cross-device computing and collaboration, announces Splashtop Business for Remote Support , a ... remote support solution. Unhappy with the escalating renewal prices and inadequate customer ...
Breaking Medicine News(10 mins):Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4
... younger adults at higher risk , THURSDAY, Sept. 17 (HealthDay ... 8 million adults in the United States seriously considered suicide ... taking their own lives. , In addition to nearly 8.3 ... to do so, and 1.1 million actually attempted it, according ...
... , , , TONBRIDGE, England, ... the greatest pharmacy innovation of the past 150 years, by leading ... pill eclipsed Coca-Cola, the electric light bulb and penicillin in a ... , The final four inventions went head-to-head in a ...
... , LOUISVILLE, Ky., Sept. 14 AAF(R) International ... the MEGAcel(TM) I filter with Helior (TM) media. ... the MEGAcel I filter is a proprietary, high-efficiency ePTFE ... significantly lower operating resistance, energy consumption is less as a result of the ...
... , , , MIDDLETOWN, ... three-year Anthem Blue Cross and Blue Shield Foundation grant to ... will receive $37,500 to fund the "Family Link" program here ... is a community-based network that connects parents of children with ...
... ... to the advisory board for PerfectServe, a healthcare communications company. , ... Knoxville, TN (PRWEB) September 15, 2009 ... communications company. The board provides guidance on innovative ways to leverage PerfectServe,s physician-contact network ...
... , , ... (AFA) today applauded Senate Finance Committee Chairman Max Baucus (D-MT) ... including cognitive impairment screening for Medicare beneficiaries in Baucus, healthcare ... , , AFA had pressed for cognitive ...
Cached Medicine News:Health News:8.3 Million U.S. Adults Considered Suicide Last Year 2Health News:Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 2Health News:AAF(R) Announces MEGAcel(TM) I Filter with Helior(TM) Media 2Health News:Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Association's 'Family Link' Program In Connecticut 2Health News:Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Association's 'Family Link' Program In Connecticut 3Health News:Robert Fanning Named to PerfectServe Advisory Board 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Proposal 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Proposal 3
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Anti Gliadin IgG Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum....
... Urinalysis WorkCell System - A Single ... per hour, with true load-and-go productivity ... Clinitek Atlas and UF-100 for complete ... systems working together deliver utmost reliability. ...
... is one of the 3 major naturally ... estrone). In terms of estrogenic activity, estriol ... Estriol is produced almost exclusively during pregnancy, ... the normal human fetus. During pregnancy, the ...
Medicine Products: